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Carbohydrates

Gram-Negative Bacteria

Results

Carbohydrates use sugar building blocks to create large,

One way that bacteria is classified is from the Gram test, which the bacteria are

multilinked structures. Although having many uses such as

stained with certain dyes to determine cell wall make up. Gram-negative bacteria do

cell metabolism, there are many potential pharmaceutical

not take up this stain, and have a specific feature of a molecule called

uses for these chemicals. Current studies include

Lipopolysaccharides (LPS). This molecule makes up the outer leaflet of the outer

carbohydrate functionalized nanoparticles for drug

membrane of most of these bacteria. Also known as an endotoxin, when these

This project is an ongoing effort in an over 12 step synthesis, starting from glucose pentaacetate and

discovery. In addition, polyethylene glycols are often

bacteria are broken down in an infection, they release these LPS molecules into the

ending with the target chemical. For the novel compound, there is a succinoyl at the 6 carbon, along

attached to bioactive molecules to improve pharmacokinetic

host’s body. For humans, this triggers the CD14 receptor, causing an overreaction by

with C14 chains at the 2 and 3 carbons. Lastly, there are phosphates at the anomeric and 4 carbon.

profiles (PEGylation). There is no question for the

the host’s own immune system in sepsis. The overreaction includes a release of

Being an ongoing effort the novel target chemical has not been synthesized yet, and the reactions is

importance of carbohydrates in the pharmaceutical

proinflammatory cytokines, which eventually can lead to damage and death of host

currently on step 9. Results and reactions are below:

discipline, and this project uses organic reactions already

cells and tissues.

known to create a novel molecule.

Reaction

Description of Reaction

Percent
Yield

1

SEt Introduction

90

2

Deacetylation

98

3

Benzylidine Introduction

85

4

C14 Introduction

90

5

Selective Benzylidine Opening

80

6

Succinoyl Introduction

74

and a multistep synthesis is determined to create

7

Benzyl Introduction

60

the target molecule. By blocking this receptor,

8

SEt Removal

85

the LPS molecule is not able to bind to it, leading

8

pMB Removal

82

Blocking the CD14 Receptor

Molecule of Interest

Using simulations of the receptors, Potential
molecules are determined that may have binding
potential to the CD14 receptor. The potential
molecules are ranked based on binding affinity,

to a lessened immune response to the release of
these molecules
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